News Author: Sharon Worcester Publish date: April 6, 2023
This study “is the largest study investigating these associations between food processing and cancer risk and therefore has greater power to detect...
News Author: Sharon Worcester Publish date: February 3, 2023
Although quality of life is recognized as a predictor of survival in patients with advanced cancer, the evidence is less clear in early-stage breas...
News Author: Sharon Worcester Publish date: December 1, 2022
Several companies have already withdrawn their respective PARP inhibitors for heavily pretreated patients with ovarian cancer.
News Author: Sharon Worcester Publish date: October 6, 2022
New and potential treatments have emerged for relapsed/refractory mantle cell lymphoma (R/RMCL), a rare but steadily increasing form of non-Hodgkin...
News Author: Sharon Worcester Publish date: September 29, 2022
The new guideline “takes a deeper dive on the use of integrative therapies, which is important because clinicians and patients need to have access ...
News Author: Sharon Worcester Publish date: September 7, 2022
“Increasing physical activity and reducing sedentary time are already recommended for cancer prevention. Our study adds further evidence that such ...
News Author: Sharon Worcester Publish date: August 31, 2022
The recall follows reports from clinicians that the pumps, which are implanted to deliver chemotherapy to treat liver tumors, were delivering medic...
News Author: Sharon Worcester Publish date: August 24, 2022
Study suggests cancer risk can be meaningfully altered by changing the amount of alcoholic beverages consumed.
News Author: Sharon Worcester Publish date: July 1, 2022
“The trial also found Copiktra was associated with a higher risk of serious side effects ...”
News Author: Sharon Worcester Publish date: June 27, 2022
Liso-cel could now become a “new standard of care for patients after failure of first-line therapy,” offering significantly improved outcomes for L...
News Author: Sharon Worcester Publish date: June 6, 2022
This is the first randomized head-to-head comparison of chemotherapy regimens in patients with this rare and deadly disease.
News Author: Sharon Worcester Publish date: June 3, 2022
Health care providers concerned that telemedicine expansion could widen cancer care disparities.
News Author: Sharon Worcester Publish date: May 31, 2022
Many patients with cancer who rely on Medicare Part D face an impossible choice: “Your money or your life.”
News Author: Sharon Worcester Publish date: May 17, 2022
Good patient compliance is important for treatment with imiquimod to be successful and that surgery might remain the treatment of choice for patien...
News Author: Sharon Worcester Publish date: April 8, 2022
Improve the ability to treat patients based on risk level and expand the use of targeted therapies.
